Iris Acquisition Corp extends business combination deadline with Liminatus Pharma to July 31, 2024

Iris Acquisition Corp

Third amendment to business combination agreement pushes outside date from March 9, 2024 to July 31, 2024.
PIPE equity and convertible note subscription agreements also extended to July 31, 2024.
All other terms of the BCA and subscription agreements remain unchanged.
This is the third extension since the original BCA was signed in November 2022.

item 1.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Iris Acquisition Corp amended Third BCA Amendment with Liminatus Pharma, LLC (effective 2024-03-09).

Action: amendment
Agreement: merger
Counterparty: Liminatus Pharma, LLC
Effective: 2024-03-09

Exact text from the filing

On March 9, 2024, Iris Acquisition Corp, a Delaware corporation (“we,” “our,” or “Iris”), Iris Parent Holding Corp., a Delaware corporation (“ParentCo”) and Liminatus Pharma, LLC, a Delaware limited liability company (“Liminatus”), entered into a third amendment (the “Third BCA Amendment”) to the Business Combination Agreement

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Iris Acquisition Corp amended Second Amendment to Convertible Note PIPE with PIPE subscriber (effective 2024-03-09).

Action: amendment
Agreement: notes offering
Counterparty: PIPE subscriber
Effective: 2024-03-09

Exact text from the filing

ParentCo, Iris and the PIPE subscriber entered into a second amendment (the “Second Amendment to Convertible Note PIPE”) to the Convertible Note Subscription Agreement

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Iris Acquisition Corp amended Second Amendment to Equity PIPE with PIPE subscriber (effective 2024-03-09).

Action: amendment
Agreement: equity purchase
Counterparty: PIPE subscriber
Effective: 2024-03-09

Exact text from the filing

ParentCo, Iris and the PIPE subscriber entered into a second amendment (the “Second Amendment to Equity PIPE”) to the Equity Subscription Agreement

View on SEC.gov

419 material agreements filed in the last 30 days. Browse all material agreements →

Source: SEC EDGAR

accession 0001104659-24-044242

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.